17Dec 2022
The Coming of Age of Topical Gene Therapy for Dystrophic Epidermolysis Bullosa

The Coming of Age of Topical Gene Therapy for Dystrophic Epidermolysis Bullosa

Dystrophic epidermolysis bullosa is a genetic disorder in which there is a loss of anchoring fibrils and structural integrity in the superficial layers of the dermis owing to mutations in the gene encoding type VII collagen (COL7A1), as explained by Payne. This process leads to painful skin blisters and various secondary illnesses. The condition can be inherited in dominant or recessive patterns and varying degrees of severity. There are currently no approved therapies for the disorder.

  • #family health

Like

Save

Share